Siriuspoint Ltd
NYSE:SPNT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Siriuspoint Ltd
Siriuspoint Ltd
Cash Equivalents
Siriuspoint Ltd
Cash Equivalents Peer Comparison
RNR
ESGR
CRE
EG
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Siriuspoint Ltd
NYSE:SPNT
|
Cash Equivalents
$867.5m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
74%
|
CAGR 10-Years
38%
|
|
|
Renaissancere Holdings Ltd
NYSE:RNR
|
Cash Equivalents
$1.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
|
|
Enstar Group Ltd
NASDAQ:ESGR
|
Cash Equivalents
$450m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-4%
|
|
|
Conduit Holdings Ltd
LSE:CRE
|
Cash Equivalents
$199.8m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Brookfield Reinsurance Ltd
TSX:BNRE
|
Cash Equivalents
$1.6B
|
CAGR 3-Years
342%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Everest Group Ltd
NYSE:EG
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Siriuspoint Ltd's Cash Equivalents?
Cash Equivalents
867.5m
USD
Based on the financial report for Mar 31, 2024, Siriuspoint Ltd's Cash Equivalents amounts to 867.5m USD.
What is Siriuspoint Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
38%
Over the last year, the Cash Equivalents growth was 14%. The average annual Cash Equivalents growth rates for Siriuspoint Ltd have been -2% over the past three years , 74% over the past five years , and 38% over the past ten years .
You don't have any saved screeners yet
